Episode 2 – Accessing US markets – Nasdaq and FDA approval

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara

In this episode Matt will be joined by Opthea CEO & Managing Director Dr Megan Baldwin and Phamaxis CEO Gary Phillips.